Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Five-year survival results of subcutaneous low-dose immunotherapy with interleukin-2 alone in metastatic renal cell cancer patients.
Bordin V, Giani L, Meregalli S, Bukovec R, Vaghi MM, Mandalà M, Paolorossi F, Ardizzoia A, Tancini G, Barni S, Frigerio F, Fumagalli L, Bordoni A, Valsuani G, Di Felice G, Lissoni P. Bordin V, et al. Among authors: frigerio f. Urol Int. 2000;64(1):3-8. doi: 10.1159/000030473. Urol Int. 2000. PMID: 10782024 Clinical Trial.
Immunoendocrine therapy with interleukin-2 (IL-2) and medroxyprogesterone acetate (MPA): a randomized study with or without MPA in metastatic renal cancer patients during IL-2 maintenance treatment after response or stable disease to IL-2 subcutaneous therapy.
Lissoni P, Barni S, Tancini G, Brivio F, Cardellini P, Vaghi M, Fossati V, Frigerio F. Lissoni P, et al. Among authors: frigerio f. Tumori. 1993 Aug 31;79(4):246-9. doi: 10.1177/030089169307900403. Tumori. 1993. PMID: 8249176 Clinical Trial.
[Clinical response and survival in metastatic renal carcinoma during subcutaneous administration of interleukin-2 alone. Subcutaneous Il-2 in renal carcinoma].
Lissoni P, Barni S, Tancini G, Cazzaniga M, Frigerio F, Chilelli M, Scardino E, Andres M, Favini P, Meroni T, Verwei F, Baccalin A, Sala M, Frea B, Kocjancic E, Rocco F. Lissoni P, et al. Among authors: frigerio f. Arch Ital Urol Androl. 1997 Feb;69(1):41-7. Arch Ital Urol Androl. 1997. PMID: 9181905 Clinical Trial. Italian.
108 results